versión imprimible

ALS Drug Development Summit

Evvnt Promotion / evvnt
24.05.2022 - 26.05.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 16:30
Temas de la conferencia
Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for drug development in ALS is exploding. With exciting new targets, revised inclusion criteria, and opportunities to implement digital biomarkers for remote and sensitive monitoring, we have never been closer to bringing meaningful therapies to patients.
Organizador profesional (PCO)
Hanson Wade
Speakers: Amir Lahav, Head of Digital R and D, Digital Healthcare Innovation, Mitsubishi Tanabe Pharma Holdings America, Andrew Wolff, Senior Vice President, Senior Fellow, Clinical Research and Development, Cytokinetics and more.

Información e inscripción:
Ms. Stephanie Nketia
Medicina General
Cuota del Congreso
USD 2199.0 - USD 4297.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichisches Rotes KreuzAMREF - African Medical and Research FoundationAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHelix - Forschung & Beratung WienÄrzte der WeltSwiss Tropical and Public Health InstituteAlumni Club Medizinische Universität WienEuropean Health Forum Gastein